Navigation Links
Early therapy aids eyesight

Early therapy for early outset glaucoma appears to slow the advancement of the disease. Researchers report immediate treatment of the most common form of glaucoma appears to impact the progression of vision loss.// This has very few significant signs. Doctors are able to detect it only in a detailed eye exam. In this study, doctors recruited 202 patients who had early stage glaucoma in one eye. Around half of the group was treated with medicine and laser to reduce the amount of internal pressure in the eye. The rest of the group was left untreated. Patients who later showed signs of developing the disease were offered treatment.

Six years into the study, doctors found the disease progressed more slowly in the treated patients than in the untreated patients. In the treated patients, eye pressure was lowered by about 25 percent. Many patients showed no disease progression during the study. However, researchers are concerned that as many as 20 percent of treated patients went on to develop glaucoma. The lead author of the study, Anders Heijl, M.D., Ph.D., suspects glaucoma progresses at different speeds in patients and those with an aggressive form of the disease were not helped much by treatment.

The most common form of glaucoma affects nearly 1.0 million people over age 45. While doctors find treating eye pressure may help slow the disease, they do not believe elevated eye pressure necessarily is the cause of the disease. Further research will be done to continue to understand the cause.


'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
11. Early Detection Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... Centennial, CO (PRWEB) , ... August 20, 2017 , ... ... in the same household? If so, you may be interested in participating in ... The purpose of this research is to understand more about the relational aspects of ...
(Date:8/19/2017)... York, New York (PRWEB) , ... August 19, ... ... Street Health has announced that it is the first organization with pending recognition ... CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live video ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology: